Literature DB >> 31321384

Protective Effects of Crude Plant Extracts against Aminochrome-induced toxicity in Human Astrocytoma Cells: Implications for Parkinson's Disease.

Viviane L Ndam Ngoungoure1,2, Patricia Muñoz2, Yousef Tizabi3, Raul Valdes2, Paul Fewou Moundipa1, Juan Segura-Aguilar2.   

Abstract

BACKGROUND/AIMS: Aminochrome, an endogenous compound formed during dopamine oxidation can induce neurotoxicity under certain aberrant conditions and induce Parkinson-like syndrome. Glutathione transferase M2 (GSTM2) activity of astrocytes by catalysing the conjugation of aminochrome with glutathione, can offer protection against aminochrome toxicity. Some medicinal toxicity through this plants may exert protective effect against aminochrome mechanism.
METHODS: In the present study, extracts from plants native to Cameroon, such as Alchornea laxiflora (leaves), Dacryodes edulis (barks), Annona muricata (seeds), Annona senegalensis (barks) were evaluated for their protection against aminochrome-induced toxicity in human glioblastoma/ astrocytoma U373MG wild type and U373MGsiGT6 cells in which GSTM2 expression was 74% silenced. The cells were pre-incubated with the plant extracts for 2 hr before addition of aminochrome (75 μM) and measurement of cell death/viability by flow cytometry after 24 hr incubation.
RESULTS: The extract of A. laxiflora (1 μg/ml), D. edulis (25 μg/ml), A. muricata (25 μg/ml) and A. senegalensis (25μg/ml) significantly decreased aminochrome-induced toxicity in U373siGST6 and U373MG cells. However, only A. laxiflora and A. muricata significantly increased the mitochondria membrane potential in U373siGST6 cells following aminochrome treatment.
CONCLUSION: The results indicate that extracts of some Cameroon plants can provide protection against aminochrome-induced toxicity and mitochondria dysfunction in human glioblastoma/astrocytoma cells. Although further identification of active components of these extracts is needed, potential usefulness of these compounds in Parkinson's disease may be suggested.

Entities:  

Keywords:  Aminochrome; Medicinal Plants; Mitochondria Dysfunction.; Neuroprotection; Neurotoxicity; U373MG cells

Year:  2019        PMID: 31321384      PMCID: PMC6639011     

Source DB:  PubMed          Journal:  Clin Pharmacol Transl Med        ISSN: 2572-7656


  29 in total

1.  Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Sergio Cardenas; Patricio Iturriaga-Vasquez; Patricio Iturra; Patricia Muñoz; Eduardo Couve; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

Review 2.  Epidemiology and etiology of Parkinson's disease: a review of the evidence.

Authors:  Karin Wirdefeldt; Hans-Olov Adami; Philip Cole; Dimitrios Trichopoulos; Jack Mandel
Journal:  Eur J Epidemiol       Date:  2011-05-28       Impact factor: 8.082

3.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; J B Clark; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1990-03       Impact factor: 5.372

Review 4.  Natural polyphenols against neurodegenerative disorders: potentials and pitfalls.

Authors:  Azadeh Ebrahimi; Hermann Schluesener
Journal:  Ageing Res Rev       Date:  2012-02-09       Impact factor: 10.895

5.  Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease.

Authors:  Patricia Muñoz; Sandro Huenchuguala; Irmgard Paris; Carlos Cuevas; Monica Villa; Pablo Caviedes; Juan Segura-Aguilar; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-04-12       Impact factor: 3.911

6.  Parkinson disease: from pathology to molecular disease mechanisms.

Authors:  David T Dexter; Peter Jenner
Journal:  Free Radic Biol Med       Date:  2013-02-04       Impact factor: 7.376

Review 7.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

8.  The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease.

Authors:  Luigi Zecca; Ruggero Fariello; Peter Riederer; David Sulzer; Alberto Gatti; Davide Tampellini
Journal:  FEBS Lett       Date:  2002-01-16       Impact factor: 4.124

9.  Cameroonian medicinal plants: pharmacology and derived natural products.

Authors:  Victor Kuete; Thomas Efferth
Journal:  Front Pharmacol       Date:  2010-10-25       Impact factor: 5.810

10.  Functional Relationships between Lipid Metabolism and Liver Regeneration.

Authors:  David A Rudnick; Nicholas O Davidson
Journal:  Int J Hepatol       Date:  2012-01-26
View more
  2 in total

1.  JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species.

Authors:  Cleonice Creusa Santos; Thyago R Cardim-Pires; Liana Shvachiy; Luis Arturo Fonseca-Fonseca; Patricia Muñoz; Áurea Maria A N Almeida; Ana Carla S Costa; Jéssica Teles-Souza; Estael Ochoa-Rodríguez; Maria de Fátima Dias Costa; Fernando L Palhano; Juan Segura-Aguilar; Deyse B Barbosa; Mayra R do Bomfim; Manoelito C Dos Santos Junior; Franco Henrique A Leite; Samuel Silva da Rocha Pita; Silvia Lima Costa; Yanier Núñez-Figueredo; Tiago Fleming Outeiro; Débora Foguel; Victor Diogenes Amaral Silva
Journal:  Neurotox Res       Date:  2022-08-23       Impact factor: 3.978

2.  Neuroscience education and research in Cameroon: Current status and future direction.

Authors:  Ngala Elvis Mbiydzenyuy; Constant Anatole Pieme; Richard E Brown; Carine Nguemeni
Journal:  IBRO Neurosci Rep       Date:  2021-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.